2015

Discussion in 'Valeant Pharmaceuticals' started by Anonymous, Dec 28, 2014 at 3:03 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Here's to a successful year
     

  2. Anonymous

    Anonymous Guest

    Lol.... Wayyy to funny! With what?!
     
  3. Anonymous

    Anonymous Guest

    Remember to listen in on the live conference (with slides!) on Valeant's 2015 outlook, 8 AM EST on Thursday, January 8.

    This one is not expected to be nearly as entertaining as their Q3 conference call last October, where Pearson and Schiller predicted an eventually successful hostile acquisition of Allergan, and where Valeant's security team had to toss out Ackman for getting into a brawl with Ramakrishna over the last cronut left on the breakfast buffet.

    Look for discussion on outstanding introduction of Jublia, with 2015 sales projections expected to be $16-billion worldwide, along with slippery avoidance about the Allergan failure, and how Valeant's lawyers are approaching those legacy insider trading class action lawsuits. Forward your questions to Laurie Little, but please note she is only accepting those questions that reflect a strong bullish outlook on Valeant's future.